Literature DB >> 9536223

Down-regulation of transforming growth factor-beta receptors I and II is seen in lesional but not non-lesional psoriatic epidermis.

T Leivo1, I Leivo, A L Kariniemi, J Keski-Oja, I Virtanen.   

Abstract

Transforming growth factor-beta s (TGF-beta s) are a family of growth factors with inhibitory effects on epithelial cell proliferation. Their effects are mediated by two interacting receptors, of which type I (T beta R-I) mediates signal transduction after interaction with type II (T beta R-II) carrying the TGF-beta ligand. We have studied the expression of T beta R-I and T beta R-II in psoriatic and normal human skin by using polyclonal rabbit antisera and immunohistochemistry. Immunohistochemical analysis revealed an intense immunoreactivity for both receptors in the basal and often also suprabasal layer of normal and non-lesional psoriatic epidermis. In contrast, all psoriatic lesions studied lacked detectable immunoreactivity of either receptor in the epidermis. The results suggest that lack of TGF-beta-mediated growth inhibition by down-regulation of TGF-beta receptor expression may play an important part in the pathogenesis of psoriasis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9536223     DOI: 10.1046/j.1365-2133.1998.02026.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  4 in total

1.  Inflammatory skin disease in K5.hTGF-beta1 transgenic mice is not dependent on the IL-23/Th17 inflammatory pathway.

Authors:  Erin L Fitch; Heather L Rizzo; Stephen E Kurtz; Keith W Wegmann; Wei Gao; Jacqueline M Benson; David J Hinrichs; Andrew Blauvelt
Journal:  J Invest Dermatol       Date:  2009-04-09       Impact factor: 8.551

Review 2.  A role for TGFbeta signaling in the pathogenesis of psoriasis.

Authors:  Gangwen Han; Cortny A Williams; Kelli Salter; Pamela J Garl; Allen G Li; Xiao-Jing Wang
Journal:  J Invest Dermatol       Date:  2009-08-27       Impact factor: 8.551

3.  Association of down-regulation of CD109 expression with up-expression of Smad7 in pathogenesis of psoriasis.

Authors:  Xin-Xin Liu; Ai-Ping Feng; Yi-Min He; Yan Li; Yan Wu; Xin Lian; Feng Hu; Jia-Wen Li; Ya-Ting Tu; Shan-Juan Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-02-03

4.  Variances in the mRNA expression profile of TGF-β1-3 isoforms and its TGF-βRI-III receptors during cyclosporin a treatment of psoriatic patients.

Authors:  Anna Michalska-Bańkowska; Dominika Wcisło-Dziadecka; Beniamin Grabarek; Ligia Brzezińska-Wcisło; Urszula Mazurek; Natalia Salwowska; Mirosław Bańkowski
Journal:  Postepy Dermatol Alergol       Date:  2018-07-19       Impact factor: 1.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.